209 related articles for article (PubMed ID: 33863366)
21. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
Valpione S; Campana L
Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
[TBL] [Abstract][Full Text] [Related]
22. Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer.
Wrzeszczynski KO; Felice V; Abhyankar A; Kozon L; Geiger H; Manaa D; London F; Robinson D; Fang X; Lin D; Lamendola-Essel MF; Khaira D; Dikoglu E; Emde AK; Robine N; Shah M; Arora K; Basturk O; Bhanot U; Kentsis A; Mansukhani MM; Bhagat G; Jobanputra V
J Mol Diagn; 2018 Nov; 20(6):822-835. PubMed ID: 30138725
[TBL] [Abstract][Full Text] [Related]
23. Creation of an Expert Curated Variant List for Clinical Genomic Test Development and Validation: A ClinGen and GeT-RM Collaborative Project.
Wilcox E; Harrison SM; Lockhart E; Voelkerding K; Lubin IM; ; Rehm HL; Kalman LV; Funke B
J Mol Diagn; 2021 Nov; 23(11):1500-1505. PubMed ID: 34384894
[TBL] [Abstract][Full Text] [Related]
24. Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.
He MM; Li Q; Yan M; Cao H; Hu Y; He KY; Cao K; Li MM; Wang K
Genome Med; 2019 Aug; 11(1):53. PubMed ID: 31443733
[TBL] [Abstract][Full Text] [Related]
25. Canine Oncopanel: A capture-based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers.
Wang G; Wu M; Durham AC; Mason NJ; Roth DB
Vet Comp Oncol; 2022 Mar; 20(1):91-101. PubMed ID: 34286913
[TBL] [Abstract][Full Text] [Related]
26. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
[TBL] [Abstract][Full Text] [Related]
27. A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.
Arango NP; Brusco L; Mills Shaw KR; Chen K; Eterovic AK; Holla V; Johnson A; Litzenburger B; Khotskaya YB; Sanchez N; Bailey A; Zheng X; Horombe C; Kopetz S; Farhangfar CJ; Routbort M; Broaddus R; Bernstam EV; Mendelsohn J; Mills GB; Meric-Bernstam F
Oncotarget; 2017 Jun; 8(26):41806-41814. PubMed ID: 28415679
[TBL] [Abstract][Full Text] [Related]
28. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
29. Genetic testing including targeted gene panel in a diverse clinical population of children with autism spectrum disorder: Findings and implications.
Kalsner L; Twachtman-Bassett J; Tokarski K; Stanley C; Dumont-Mathieu T; Cotney J; Chamberlain S
Mol Genet Genomic Med; 2018 Mar; 6(2):171-185. PubMed ID: 29271092
[TBL] [Abstract][Full Text] [Related]
30. Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors.
Zhao J; Reuther J; Scozzaro K; Hawley M; Metzger E; Emery M; Chen I; Barbosa M; Johnson L; O'Connor A; Washburn M; Hartje L; Reckase E; Johnson V; Zhang Y; Westheimer E; O'Callaghan W; Malani N; Chesh A; Moreau M; Daber R
Mol Diagn Ther; 2023 Nov; 27(6):753-768. PubMed ID: 37632661
[TBL] [Abstract][Full Text] [Related]
31. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
Mu W; Lu HM; Chen J; Li S; Elliott AM
J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
[TBL] [Abstract][Full Text] [Related]
32. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
[TBL] [Abstract][Full Text] [Related]
33. Huvariome: a web server resource of whole genome next-generation sequencing allelic frequencies to aid in pathological candidate gene selection.
Stubbs A; McClellan EA; Horsman S; Hiltemann SD; Palli I; Nouwens S; Koning AH; Hoogland F; Reumers J; Heijsman D; Swagemakers S; Kremer A; Meijerink J; Lambrechts D; van der Spek PJ
J Clin Bioinforma; 2012 Nov; 2(1):19. PubMed ID: 23164068
[TBL] [Abstract][Full Text] [Related]
34. Interplay between probe design and test performance: overlap between genomic regions of interest, capture regions and high quality reference calls influence performance of WES-based assays.
Pranckeviciene E; Racacho L; Ghani M; Nfonsam L; Potter R; Sinclair-Bourque E; Mettler G; Smith A; Bronicki L; Huang L; Jarinova O
Hum Genet; 2021 Feb; 140(2):289-297. PubMed ID: 32627054
[TBL] [Abstract][Full Text] [Related]
35. Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies.
Talsania K; Shen TW; Chen X; Jaeger E; Li Z; Chen Z; Chen W; Tran B; Kusko R; Wang L; Pang AWC; Yang Z; Choudhari S; Colgan M; Fang LT; Carroll A; Shetty J; Kriga Y; German O; Smirnova T; Liu T; Li J; Kellman B; Hong K; Hastie AR; Natarajan A; Moshrefi A; Granat A; Truong T; Bombardi R; Mankinen V; Meerzaman D; Mason CE; Collins J; Stahlberg E; Xiao C; Wang C; Xiao W; Zhao Y
Genome Biol; 2022 Dec; 23(1):255. PubMed ID: 36514120
[TBL] [Abstract][Full Text] [Related]
36. A New Integrated Newborn Screening Workflow Can Provide a Shortcut to Differential Diagnosis and Confirmation of Inherited Metabolic Diseases.
Ko JM; Park KS; Kang Y; Nam SH; Kim Y; Park I; Chae HW; Lee SM; Lee KA; Kim JW
Yonsei Med J; 2018 Jul; 59(5):652-661. PubMed ID: 29869463
[TBL] [Abstract][Full Text] [Related]
37. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. A new method to accurately identify single nucleotide variants using small FFPE breast samples.
Fortunato A; Mallo D; Rupp SM; King LM; Hardman T; Lo JY; Hall A; Marks JR; Hwang ES; Maley CC
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34117742
[TBL] [Abstract][Full Text] [Related]
40. Rare variant phasing using paired tumor:normal sequence data.
Buckley AR; Ideker T; Carter H; Schork NJ
BMC Bioinformatics; 2019 May; 20(1):265. PubMed ID: 31132991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
